Readystate Asset Management LP Purchases Shares of 101,000 Senseonics Holdings, Inc. Common Stock $SENS

Readystate Asset Management LP purchased a new stake in Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 101,000 shares of the company’s stock, valued at approximately $574,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Ausdal Financial Partners Inc. raised its stake in shares of Senseonics Holdings, Inc. Common Stock by 50.0% during the 3rd quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company’s stock worth $46,000 after acquiring an additional 35,000 shares in the last quarter. GSK plc acquired a new stake in Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $60,000. The Manufacturers Life Insurance Company acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $65,000. State of Wyoming acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $67,000. Finally, Kestra Advisory Services LLC purchased a new position in Senseonics Holdings, Inc. Common Stock in the first quarter worth $68,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Price Performance

NASDAQ:SENS opened at $9.63 on Tuesday. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $11.58. The company has a market cap of $402.53 million, a PE ratio of -4.32 and a beta of 1.08. The company’s 50 day moving average is $6.80 and its two-hundred day moving average is $6.68.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%.The company had revenue of $14.48 million during the quarter. Analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Stifel Nicolaus reduced their price target on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Monday, May 11th. Wall Street Zen raised Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. HC Wainwright dropped their target price on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, May 12th. Weiss Ratings lowered Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, August 12th. Finally, Mizuho decreased their price target on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, July 15th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.20.

Insider Activity

In other news, Director Douglas Roeder bought 13,953 shares of the business’s stock in a transaction that occurred on Wednesday, August 19th. The shares were purchased at an average cost of $8.98 per share, with a total value of $125,297.94. Following the transaction, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 4.70% of the stock is currently owned by insiders.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.